A novel toll-like receptor 4 (TLR4) antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis Running Title: Dual effect of anti-TLR4 antibody in murine colitis (original) (raw)
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis
davide di fusco
European Journal of Clinical Pharmacology, 2020
View PDFchevron_right
The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease
Piotr Smolewski
Immunology, 2008
View PDFchevron_right
Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease: Toll-like receptor expression in inflammatory bowel disease
András Arató
Clinical and Experimental Immunology, 2007
View PDFchevron_right
Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis
Hilda Yanti
American Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
View PDFchevron_right
Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP
Catalina Abad
Journal of Leukocyte Biology, 2005
View PDFchevron_right
Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis
A. Kraneveld
Mucosal Immunology, 2014
View PDFchevron_right
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
G. Bromfield
Genes and Immunity, 2007
View PDFchevron_right
Increased expression of Toll‐like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease
Adám Vannay
Clinical & …, 2008
View PDFchevron_right
Activation of toll-like receptor 3 protects against DSS-induced acute colitis
Andrew Neish
Inflammatory Bowel Diseases, 2007
View PDFchevron_right
Carvalho, F.A. et al. Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 61, 373-384
Omry Koren
Gut
View PDFchevron_right
Interleukin11 Reduces TLR4Induced Colitis in TLR2Deficient Mice and Restores Intestinal STAT3 Signaling
Sanjoy Ghosh
Gastroenterology, 2010
View PDFchevron_right
Differential expression of key regulators of Toll-like Receptors in Ulcerative Colitis and Crohn's disease: A role for Tollip and PPARγ?
Trevor Darby
Clinical & Experimental Immunology, 2015
View PDFchevron_right
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice
Jason Law
Journal of Clinical Investigation, 2010
View PDFchevron_right
T2074 The Expression of Toll-Like Receptor 4 in Colon Mucosa is as up-Regulated in Irritable Bowel Syndrome as it is in Inflammatory Bowel Disease
Greger Lindberg
Gastroenterology, 2010
View PDFchevron_right
Association between Toll-like receptor 4 and inflammatory bowel disease
klaas jansen
Inflammatory Bowel Diseases, 2005
View PDFchevron_right
Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice
Wanyin Deng
Infection and Immunity, 2006
View PDFchevron_right
Proinflammatory properties of IL-4 in the intestinal microenvironment
Stephen Collins
AJP: Gastrointestinal and Liver Physiology, 2005
View PDFchevron_right
IL-4 Receptor-Alpha Signalling of Intestinal Epithelial Cells, Smooth Muscle Cells, and Macrophages Plays a Redundant Role in Oxazolone Colitis
Patricia Odhiambo
Mediators of Inflammation, 2020
View PDFchevron_right
Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis
Caixia Ma
Cellular Microbiology, 2007
View PDFchevron_right
Toll-Like Receptor 4-Mediated Regulation of Spontaneous Helicobacter-Dependent Colitis in IL-10–Deficient Mice
Cathryn Nagler, Guénolée Prioult
Gastroenterology, 2009
View PDFchevron_right
Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome
Greger Lindberg
BioMed Research International, 2017
View PDFchevron_right
Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease
András Falus
2011
View PDFchevron_right
Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis
Uday Ghoshal
Journal of Neurogastroenterology and Motility, 2018
View PDFchevron_right
New concepts in the pathophysiology of inflammatory bowel disease
Giorgos Bamias, S. De La Rue
Annals of internal medicine, 2005
View PDFchevron_right
Regulation of mucosal immune responses — the missing link in IBD?
Kenneth Beagley
Inflammatory Bowel Disease, 1994
View PDFchevron_right
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fergus Shanahan
Clinical and Experimental Immunology, 2015
View PDFchevron_right
The Role of Innate Immunity Receptors in the Pathogenesis of Inflammatory Bowel Disease
Heitor S P de Souza
Mediators of inflammation, 2015
View PDFchevron_right
TLR Signaling-induced CD103-expressing Cells Protect Against Intestinal Inflammation
Julia-Stefanie Frick
Inflammatory Bowel Diseases, 2015
View PDFchevron_right
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Warren Strober
Gastroenterology, 2011
View PDFchevron_right